Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Degtyarev

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Scientific Reports|June 15, 2017
Features of electron gas in InAs nanowires imposed by interplay between nanowire geometry, doping and surface statesV E Degtyarev, S V Khazanova, N V Demarina
Microbiology Resource Announcements|May 20, 2024
The complete coding sequence of Influenza A/Unknown/Chelyabinsk/206/H7N4S Feoktistova, E Degtyarev, I Abramov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trialM H Kulke, P Ruszniewski, E Van Cutsem, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Scientific Reports|June 15, 2017
Features of electron gas in InAs nanowires imposed by interplay between nanowire geometry, doping and surface statesV E Degtyarev, S V Khazanova, N V Demarina
Microbiology Resource Announcements|May 20, 2024
The complete coding sequence of Influenza A/Unknown/Chelyabinsk/206/H7N4S Feoktistova, E Degtyarev, I Abramov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trialM H Kulke, P Ruszniewski, E Van Cutsem, et al.
Pageof 1